Search research articles
Contact Us
Filters
Showing results (391-400 of 744) with videos related to
Page
of 75
Sort By:
European Urology Oncology
|
June 18, 2019
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer
Armando Stabile, Paolo Dell'Oglio, Matteo Soligo, et al.
Plos One
|
April 4, 2015
Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis
Jennifer Mason Lobo, Adam P Dicker, Christine Buerki, et al.
The Prostate
|
May 26, 2026
Characterizing the Activity of Inflammasome-Related Genes and Their Association With Oncological Outcomes in Prostate Cancer
Alireza Ghoreifi, Mohammed Alshalalfa, Elai Davicioni, et al.
The Journal of Urology
|
July 25, 2016
Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with <sup>11</sup>C-Choline Positron Emission Tomography and Multiparametric Magnetic Resonance Imaging
Ilya Sobol, Harras B Zaid, Rimki Haloi, et al.
Urologic Oncology
|
June 11, 2018
Temporal trends in venous thromboembolism after radical cystectomy
Timothy D Lyon, Matthew K Tollefson, Paras H Shah, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2008
Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline
Kathryn A Martin, R Jeffrey Chang, David A Ehrmann, et al.
World Journal of Urology
|
May 17, 2014
Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy
Marisa M Clifton, Sarah P Psutka, Stephen A Boorjian, et al.
Journal of Neuro-Oncology
|
October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma
Mark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.
European Urology
|
March 20, 2013
Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: the impact of competing causes of mortality and patient stratification
Firas Abdollah, Stephen Boorjian, Cesare Cozzarini, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
December 4, 2018
TPT sulfonate, a single, oral dose schistosomicidal prodrug: In vivo efficacy, disposition and metabolic profiling
Alan R Wolfe, R Jeffrey Neitz, Mark Burlingame, et al.
Page
of 75
Search research articles
Search
Showing results (391-400 of 744) with videos related to
Sort By:
Page
of 75
European Urology Oncology
|
June 18, 2019
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer
Armando Stabile, Paolo Dell'Oglio, Matteo Soligo, et al.
Plos One
|
April 4, 2015
Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis
Jennifer Mason Lobo, Adam P Dicker, Christine Buerki, et al.
The Prostate
|
May 26, 2026
Characterizing the Activity of Inflammasome-Related Genes and Their Association With Oncological Outcomes in Prostate Cancer
Alireza Ghoreifi, Mohammed Alshalalfa, Elai Davicioni, et al.
The Journal of Urology
|
July 25, 2016
Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with <sup>11</sup>C-Choline Positron Emission Tomography and Multiparametric Magnetic Resonance Imaging
Ilya Sobol, Harras B Zaid, Rimki Haloi, et al.
Urologic Oncology
|
June 11, 2018
Temporal trends in venous thromboembolism after radical cystectomy
Timothy D Lyon, Matthew K Tollefson, Paras H Shah, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2008
Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline
Kathryn A Martin, R Jeffrey Chang, David A Ehrmann, et al.
World Journal of Urology
|
May 17, 2014
Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy
Marisa M Clifton, Sarah P Psutka, Stephen A Boorjian, et al.
Journal of Neuro-Oncology
|
October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma
Mark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.
European Urology
|
March 20, 2013
Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: the impact of competing causes of mortality and patient stratification
Firas Abdollah, Stephen Boorjian, Cesare Cozzarini, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
December 4, 2018
TPT sulfonate, a single, oral dose schistosomicidal prodrug: In vivo efficacy, disposition and metabolic profiling
Alan R Wolfe, R Jeffrey Neitz, Mark Burlingame, et al.
Page
of 75